Major outer membrane protein Omp25 of Brucella suis is involved in inhibition of tumor necrosis factor alpha production during infection of human macrophages

作者: Véronique Jubier-Maurin , Rose-Anne Boigegrain , Axel Cloeckaert , Antoine Gross , Maria-Teresa Alvarez-Martinez

DOI: 10.1128/IAI.69.8.4823-4830.2001

关键词:

摘要: Brucella spp. can establish themselves and cause disease in humans animals. The mechanisms by which evade the antibacterial defenses of their host, however, remain largely unknown. We have previously reported that live brucellae failed to induce tumor necrosis factor alpha (TNF-alpha) production upon human macrophage infection. This inhibition is associated with a nonidentified protein released into culture medium. Outer membrane proteins (OMPs) gram-negative bacteria been shown modulate functions, including cytokine production. Thus, we analyzed effects two major OMPs (Omp25 Omp31) suis 1330 (wild-type [WT] B. suis) on TNF-alpha For this purpose, omp25 omp31 null mutants (Deltaomp25 Deltaomp31 suis, respectively) were constructed for ability activate macrophages secrete TNF-alpha. showed that, contrast WT or Deltaomp25 induced when phagocytosed macrophages. complementation (Deltaomp25-omp25 mutant) significantly reversed effect: Deltaomp25-omp25 suis-infected secreted less than did infected mutant. Furthermore, pretreatment an anti-Omp25 monoclonal antibody directed against epitope exposed at surface resulted substancial during These observations demonstrated Omp25 involved negative regulation infection

参考文章(40)
J Goldstein, T Hoffman, C Frasch, E F Lizzio, P R Beining, D Hochstein, Y L Lee, R D Angus, B Golding, Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccines. Infection and Immunity. ,vol. 60, pp. 1385- 1389 ,(1992) , 10.1128/IAI.60.4.1385-1389.1992
A. Cloeckaert, J.-M. Verger, M. Grayon, O. Grepinet, Restriction site polymorphism of the genes encoding the major 25 kDa and 36 kDa outer-membrane proteins of Brucella Microbiology. ,vol. 141, pp. 2111- 2121 ,(1995) , 10.1099/13500872-141-9-2111
Tom Maniatis, Joseph Sambrook, E. F. Fritsch, Molecular Cloning: A Laboratory Manual ,(2001)
J P Vendrell, A M Conge, M Segondy, S Lombroso, M F Huguet, A Bertrand, F Janbon, A Serre, In vitro antibody secretion by peripheral blood mononuclear cells as an expression of the immune response to Brucella spp. in humans. Journal of Clinical Microbiology. ,vol. 30, pp. 2200- 2203 ,(1992) , 10.1128/JCM.30.8.2200-2203.1992
Nieves Vizcaíno, Axel Cloeckaert, Michel S. Zygmunt, Luis Fernández-Lago, Molecular characterization of a Brucella species large DNA fragment deleted in Brucella abortus strains: evidence for a locus involved in the synthesis of a polysaccharide. Infection and Immunity. ,vol. 67, pp. 2700- 2712 ,(1999) , 10.1128/IAI.67.6.2700-2712.1999
C Gamazo, I Moriyón, Release of outer membrane fragments by exponentially growing Brucella melitensis cells. Infection and Immunity. ,vol. 55, pp. 609- 615 ,(1987) , 10.1128/IAI.55.3.609-615.1987
E Caron, T Peyrard, S Köhler, S Cabane, J P Liautard, J Dornand, Live Brucella spp. fail to induce tumor necrosis factor alpha excretion upon infection of U937-derived phagocytes. Infection and Immunity. ,vol. 62, pp. 5267- 5274 ,(1994) , 10.1128/IAI.62.12.5267-5274.1994
D M Fernandes, R Benson, C L Baldwin, Lack of a role for natural killer cells in early control of Brucella abortus 2308 infections in mice. Infection and Immunity. ,vol. 63, pp. 4029- 4033 ,(1995) , 10.1128/IAI.63.10.4029-4033.1995
H M Vordermeier, P Hoffmann, F O Gombert, G Jung, W G Bessler, Synthetic peptide segments from the Escherichia coli porin OmpF constitute leukocyte activators. Infection and Immunity. ,vol. 58, pp. 2719- 2724 ,(1990) , 10.1128/IAI.58.8.2719-2724.1990
Charriaut C, Dubray G, Evidence of three major polypeptide species and two major polysaccharide species in the Brucella outer membrane. Annals of veterinary research. ,vol. 14, pp. 311- 318 ,(1983)